Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
181.5 EUR | +2.08% | +2.83% | +13.72% |
Apr. 17 | Esker: new record sales for Q1 | CF |
Apr. 16 | Esker Provides Sales Guidance for Fiscal Year 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 48% by 2025.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With an expected P/E ratio at 71.4 and 54.64 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.72% | 1.14B | - | ||
+11.17% | 322B | B- | ||
+24.75% | 216B | B+ | ||
+2.41% | 149B | B | ||
+10.65% | 56.27B | D+ | ||
+8.71% | 32.13B | B+ | ||
-4.57% | 27.45B | C+ | ||
+103.03% | 22.62B | D+ | ||
+20.22% | 19.55B | B- | ||
+13.06% | 14.69B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ALESK Stock
- Ratings Esker